Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24525N0683
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,168
Award facts
- Contract value 100% obligated
- $13,168.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $13,168.39 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5) for Jynarque 90mg-30mg, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The delivery order, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, represents a continuation of supply under the company's broader Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). No set-aside designation was utilized for this award. The medication will be delivered to the VA facility in Pittsburgh, Pennsylvania, supporting VISN 5's pharmaceutical supply needs.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle with the VA National Acquisition Center, which includes an $83.3 million Blanket Purchase Agreement for Jynarque and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. The company's established position as a primary supplier of specialized pharmaceuticals to multiple Veterans Integrated Service Networks enables efficient procurement of critical medications across the VA healthcare system, with delivery orders ranging from $10,000 to $113,000 across multiple VISN locations nationwide.
Quick answers
Who was awarded contract 36C24525N0683?
36C24525N0683 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on June 6, 2025.
How much is contract 36C24525N0683 worth?
The government has obligated $13,168 on 36C24525N0683.
Is contract 36C24525N0683 an order under another contract?
Yes. 36C24525N0683 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0683 competed?
The extent of competition for 36C24525N0683 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award